-- Evofem's Cost to Manufacture PHEXXI will Decrease by 55% - 60% -- SAN DIEGO, March 26, 2025 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) (Evofem or the Company) today announced that it has entered into a License and Supply Agreement (L&S Agreement) with Windtree Therapeutics,...
Hence then, the article about evofem expects significant reduction in phexxi manufacturing cost through agreement with windtree therapeutics was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Evofem Expects Significant Reduction in PHEXXI Manufacturing Cost Through Agreement with Windtree Therapeutics )
Also on site :
- I-70 closed in Glenwood Canyon for safety concerns, police activity
- Iran protests latest: Trump to be briefed on military strike options after he orders new sanctions on Tehran
- What we know about the alleged arson at Mississippi’s largest and oldest synagogue